New Zealand markets open in 3 hours 45 minutes
  • NZX 50

    12,090.93
    +123.21 (+1.03%)
     
  • NZD/USD

    0.6434
    +0.0001 (+0.02%)
     
  • ALL ORDS

    7,709.70
    +23.60 (+0.31%)
     
  • OIL

    76.81
    -2.06 (-2.61%)
     
  • GOLD

    1,938.40
    -6.90 (-0.35%)
     

Why Shares of Provention Bio Went Up 30.3% in November

Why Shares of Provention Bio Went Up 30.3% in November

Shares of Provention Bio (NASDAQ: PRVB) rose 30.3% in November, according to data from S&P Global Intelligence. The pharmaceutical company closed out October at $6.94 and opened November at $7. The move up can be directly tied to the approval of Provention therapy Tzield (teplizumab-mzwv) by the Food and Drug Administration (FDA) on Nov. 17.